The Children’s Tumor Foundation is delighted to announce that a Foundation-spearheaded paper outlining progress in NF2 clinical trials and strategies for further accelerating these trials has been accepted for publication in the American Journal of Medical Genetics. This paper, “Consensus Recommendations for Current Treatments and Accelerating Clinical Trials for Patients with Neurofibromatosis Type 2” was authored by 17 international NF2 clinical and research experts as an outcome of a Children’s Tumor Foundation-convened Workshop to accelerate NF2 clinical trials hosted in Las Vegas, NV last year. Lead authors of the report are Dr. Jaishri Blakeley (Johns Hopkins University), Dr. D. Gareth Evans (University of Manchester) and Dr. Marco Giovannini (House Ear Institute). This is the second NF2 clinical trials consensus paper published under the auspices of the Children’s Tumor Foundation. The first paper, published in Clinical Cancer Research and the result of a 2007 Foundation NF2 Workshop, helped initiate collaborations for the pioneering of NF2 clinical trials in the past few years.
The new AJMG publication should appear in the near future.
